Northern Financial Advisors Inc Gilead Sciences, Inc. Transaction History

Northern Financial Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$71.58 - $87.29 $45,095 - $54,992	-630 Reduced 15.72%	3,378 $247 Million
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $43,375 - $49,189	592 Added 17.33%	4,008 $325 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $11,164 - $12,181	-151 Reduced 4.23%	3,416 $256 Million
Q2 2023 Jul 21, 2023	SELL	$76.01 - $86.7 $1,748 - $1,994	-23 Reduced 0.64%	3,567 $275 Million
Q1 2023 Apr 26, 2023	BUY	$77.31 - $88.08 $53,653 - $61,127	694 Added 23.96%	3,590 $298 Million
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $180,478 - $259,105	2,896 New	2,896 $249 Million

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Northern Financial Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Financial Advisors Inc with notifications on news.